SCHEMBL16764187

SCHEMBL16764187

CC(C)(C)OC(=O)N1CCCC(n2ccc3cc(C4CC4)cc(F)c3c2=O)C1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 4/20 0.43
▸ FPR2 P25090 1/20 0.41
▸ HCAR1 Q9BXC0 1/20 0.40
▸ TRPV3 Q8NET8 2/20 0.40
▸ PDE4B Q07343 1/20 0.38
▸ BTK Q06187 2/20 0.37
▸ USP30 Q70CQ3 3/20 0.37
▸ HDAC4 P56524 1/20 0.37
▸ HDAC6 Q9UBN7 1/20 0.37
▸ SCN9A Q15858 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ GLA P06280 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ RECQL P46063 1/20 0.36
▸ HSD17B10 Q99714 1/20 0.36
▸ EGFR P00533 1/20 0.36
▸ SRC P12931 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16764188 1.00 HRH3 (0.43) HRH3FPR2HCAR1TRPV3PDE4B
SCHEMBL16333804 0.83 BTK (0.52) HRH3FPR2HCAR1TRPV3BTK
SCHEMBL25150828 0.82 USP30 (0.42) FPR2TRPV3BTKUSP30EGFR
SCHEMBL30398655 0.82 USP30 (0.42) FPR2TRPV3BTKUSP30EGFR
SCHEMBL20867825 0.80 BTK (0.39) BTK
SCHEMBL30186818 0.76 DPP4 (0.42) FPR2HCAR1TRPV3USP30KDM4E
SCHEMBL25151191 0.76 DPP4 (0.42) FPR2HCAR1TRPV3USP30KDM4E
SCHEMBL30398712 0.76 FPR2 (0.49) FPR2HCAR1USP30HDAC4HDAC6
SCHEMBL18296156 0.76 FPR2 (0.49) FPR2HCAR1USP30HDAC4HDAC6
SCHEMBL16763432 0.75 BTK (0.49) TRPV3PDE4BBTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200079754-A1 INHIBITORS OF BRUTONS TYROSINE KINASE PHARMACYCLICS LLC (US) 2020-03-12 — — US disclosed
US-20190100505-A1 INHIBITORS OF BRUTON'S TYROSINE KINASE PHARMACYCLICS LLC (US) 2019-04-04 — — US disclosed
US-20180030027-A1 INHIBITORS OF BRUTON'S TYROSINE KINASE PHARMACYCLICS LLC (US) 2018-02-01 — — US disclosed
US-9656988-B2 Inhibitors of Bruton's tyrosine kinase PHARMACYCLICS LLC (US) 2017-05-23 — — US disclosed
US-20160355498-A1 INHIBITORS OF BRUTON'S TYROSINE KINASE PHARMACYCLICS, INC. 2016-12-08 — — US disclosed
US-9382246-B2 Inhibitors of Bruton's tyrosine kinase PHARMACYCLICS LLC (US) 2016-07-05 — — US disclosed
US-20150158865-A1 INHIBITORS OF BRUTON'S TYROSINE KINASE PHARMACYCLICS LLC 2015-06-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180030027-A1 INHIBITORS OF BRUTON'S TYROSINE KINASE BTK, LYN, LCK HRH3 1934/4885FPR2 1472/4885HCAR1 4374/4885
US-20200079754-A1 INHIBITORS OF BRUTONS TYROSINE KINASE BTK, LYN, LCK HRH3 1770/4885FPR2 1692/4885HCAR1 4238/4885
US-20160355498-A1 INHIBITORS OF BRUTON'S TYROSINE KINASE BTK, LYN, LCK HRH3 1935/4885FPR2 1522/4885HCAR1 4404/4885
US-20190100505-A1 INHIBITORS OF BRUTON'S TYROSINE KINASE BTK, LYN, LCK HRH3 1935/4885FPR2 1522/4885HCAR1 4404/4885
US-20150158865-A1 INHIBITORS OF BRUTON'S TYROSINE KINASE BTK, LYN, LCK HRH3 1935/4885FPR2 1522/4885HCAR1 4404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback